Multivariate analysis of survival, local control, and time to distant metastases in patients with unresectable non-small-cell lung carcinoma treated with 3-dimensional conformal radiation therapy with or without concurrent chemotherapy

Michal J. Wolski, Ajay Bhatnagar, John C. Flickinger, Chandra Belani, Suresh Ramalingam, Joel S. Greenberger, Joel S. Greenberger

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Background: Three-dimensional (3D) conformal radiation therapy (CRT) and chemotherapy have recently improved lung cancer management. Patients and methods: We reviewed outcomes in 68 patients with unresectable stage HII non-small-cell lung cancer. Treatment consisted of 3D CRT alone or with concurrent chemotherapy (CCR). Results: Concurrent chemotherapy improved survival, to a median of 17 months ± 4.9 months, compared with 8 months ± 4.1 months for the radiation therapy (RT) alone group (P = 0.0347). The 2- and 5-year survival rates were 40.3% ± 7.7% and 14.1% ± 6.4%, repectively, with CCR, compared with 19.6% ± 9.6% and 0, respectively, for RT alone. In a subgroup analysis for age > 65, patients who received CCR (n = 20) had significantly improved survival and local control (P = 0.005 and P = 0.0286, respectively). Acute esophageal toxicity Radiation Therapy Oncology Group grade ≥ 3 was significantly higher in the CCR group and correlated with the RT dose (19% in CCR vs. 0 in RT, P = 0.0234; P = 0.050). The overall incidences of esophageal and pulmonary toxicity grade ≥ 3 were 20.6% and 5.9%, respectively. Conclusion: Our study confirms that CCR is associated with improved survival over RT alone, with a tolerable increase in acute toxicity.

Original languageEnglish (US)
Pages (from-to)100-106
Number of pages7
JournalClinical Lung Cancer
Volume7
Issue number2
DOIs
StatePublished - Jan 1 2005

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Multivariate analysis of survival, local control, and time to distant metastases in patients with unresectable non-small-cell lung carcinoma treated with 3-dimensional conformal radiation therapy with or without concurrent chemotherapy'. Together they form a unique fingerprint.

  • Cite this